STAT Mar 14
Paid articlePaywallGrail CEO steps down after trial setback:
Today's biotech news covers Grail CEO stepping down, Epstein's pal returning to biotech ...
statnews.com/2026/03/13/biotech-news-grail-ceo-steps-down-after-trial-setback/
Story Details
| Last Updated | |
| Total Articles | 2 |
Main Topics
coming together of parties to a dispute, to present information in a tribunal
Similar to This
Previous
Opinion6 biotech stocks for a volatile bull market: Jon Erlichman: Biotech stocks can be volatile, even in a bull market. So how do investors avoid the traps?
bnnbloomberg.ca/ticker-take/2026/11/06/6-biotech-stocks-for-a-volatile-bull-market-jon-erlichman/
STAT Nov 04
Paid articlePaywall Former Madrigal Pharmaceuticals executive alleges coverup of safety issues tied to its drug
statnews.com/2026/11/04/former-madrigal-pharmaceuticals-executive-rezdiffra-lawsuit/
Ray Dalio Shares The 'Holy Grail' Of Investing And Says Beating The Market Is Harder Than Winning An Olympic…
benzinga.com/personal-finance/management/26/11/62786032/ray-dalio-shares-the-holy-grail-of-investing-and-says-beating-the-market-is-harder-than-winning-an-olympic-medal-we-must-be-humble-about-that
Paid articlePaywall Grail Names ‘Skateland’ Director Anthony Burns As In-House Creative Producer: Grail Names 'Skateland' Director Anthony Burns As In-House Creative ...
deadline.com/2026/11/grail-skateland-director-anthony-burns-creative-producer-1237211655/
Anthropic is running its own drug programs after acquiring a one-person biotech: Anthropic released early results from drug development work with six partners ...
qz.com/anthropic-mithril-medicine-acquisition-drug-programs-102826
Formation raises $600 million to fix AI's biotech bottleneck: It's a new spin on biotech's hub-and-spoke model.
axios.com/2026/10/29/formation-bio-ai-drug-development
San Diego biotech lays off nearly all its staff after drug trial failure and 2 patient deaths
sandiegouniontribune.com/2026/10/27/san-diego-biotech-lays-off-nearly-all-its-staff-after-drug-trial-failure-and-2-patient-deaths/
STAT Oct 26
Paid articlePaywall Merck ADC drug cut risk of death by one-third in advanced endometrial cancer: ESMO news: Merck and Kelun-Biotech's Phase 3 TroFuse-005 study reveals sac-TMT ...
statnews.com/2026/10/26/merck-kelun-sac-tmt-endometrial-cancer-study-esmo-2026/
Cramer says these blue-chip stocks are among the best ways to invest in the AI boom
cnbc.com/2026/10/06/jim-cramer-ai-stocks.html
STAT Jul 03
Paid articlePaywall Halfway into the year, biotech is booming: In this week's edition of "Adam's Biotech Scorecard," Adam steps back to look at the sectors ...
statnews.com/2026/07/02/biotech-sector-booms-capricor-fda-meeting/
I tried the next frontier in cancer screening. I'm dubious: I tried the $950 blood test Silicon Valley thinks can revolutionize cancer screening ...
businessinsider.com/i-tried-the-next-frontier-in-cancer-screening-blood-colon-2026-4
STAT Mar 19
Paid articlePaywall Six drugmakers, six months: Charting the FDA’s course in the post-Prasad era: In this week's "Adam's Biotech Scorecard," Adam points out what ...
statnews.com/2026/03/19/biotech-scorecard-rare-disease-drugs-fda-decisions/
STAT Mar 17
Paid articlePaywall Senator blasts GSK inhaler practices, calls for reform: Today's biotech news includes Trump adding pressure to codify MFN, a judge stalling Kennedy's ...
statnews.com/2026/03/17/biotech-news-senator-blasts-gsk-inhaler-practices/
STAT Mar 16
Paid articlePaywall Two more drugmakers join TrumpRx: Today's biotech news includes more drugmakers joining TrumpRx, Medicare delays stalling breakthrough devices, and more.
statnews.com/2026/03/16/biotech-news-two-more-drugmakers-join-trumprx/
STAT Mar 09
Paid articlePaywall Xenon Pharmaceuticals’ seizure drug shows strong efficacy in late-stage trial: The company says it will seek approval based on better-than-expected data in a ...
statnews.com/2026/03/09/xenon-pharmaceuticals-azetukalner-epilepsy-fos/
STAT Mar 09
Paid articlePaywall A setback for Roche's breast cancer drug: Wall Street's verdict on Prasad, generic semaglutide's new pricing, and other biotech news
statnews.com/2026/03/09/biotech-news-setback-for-roche-breast-cancer-drug/
STAT Mar 05
Paid articlePaywall A drug company with a side of gold?: Today's biotech news covers: GLP-1s and addiction, a gene therapy company and a mining corporation ...
statnews.com/2026/03/05/biotech-news-klotho-neurosciences-share-greenland-mining-company/
STAT Mar 04
Paid articlePaywall FDA warns more telehealth firms about compounded GLP-1s: Today's biotech news covers Moderna to pay major settlement in Roivant patent case ...
statnews.com/2026/03/04/biotech-news-fda-warns-telehealth-about-glp-1-compounding/
Paid articlePaywall This once-hot cancer-detection company’s stock got cut in half after a failed trial
marketwatch.com/story/this-once-hot-cancer-detection-companys-stock-got-cut-in-half-after-a-failed-trial-1c97caa5
Next